101 – 110 of 113
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Orthostatic blood pressure response, carotid intima-media thickness, and plasma fibrinogen in older nondiabetic adults.
(
- Contribution to journal › Article
-
Mark
Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
(
- Contribution to journal › Article
- 2011
-
Mark
Food patterns, inflammation markers and incidence of cardiovascular disease: the Malmö Diet and Cancer study.
(
- Contribution to journal › Article
-
Mark
The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmo Preventive Project
(
- Contribution to journal › Article
- 2009
-
Mark
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
(
- Contribution to journal › Article
-
Mark
Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes.
(
- Contribution to journal › Article
- 2008
-
Mark
Lp-PLA(2) activity and mass are associated with increased incidence of ischemic stroke - A population-based cohort study from Malmo, Sweden
(
- Contribution to journal › Article
-
Mark
Vildagliptin improves alpha cell glucose sensing in patients with type 2 diabetes
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.36-37(
- Contribution to journal › Published meeting abstract
-
Mark
Lipoprotein-associated phospholipase A2 (Lp-PLA2) Impact and role as cardiovascular risk marker
(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
Elevated Lp-PLA2 Levels Add Prognostic Information to The Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects.
(
- Contribution to journal › Article